Merck & Co Inc
NYSE: MRK
$83.36
-$0.66 (-0.79%)
Closing Price on July 12, 2025
MRK Articles
These four mega-cap stocks offer the best total return potential for 2025. Plus, they are all rated Buy at some of the top firms on Wall Street.
Published:
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The ‘Dogs of the Dow’ is a well-known strategy first...
Published:
Last Updated:
These four large-cap dividend stocks offer value, upside potential, and strong dividend coverage. They are top picks for the coming year.
Published:
These three dividend-paying Dow stocks dominate the health care sector and look like incredible values now for growth and income investors.
Published:
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
Many investors can pigeon hole buying dividend stocks as a particular investment style that may not fit with their long-term goals. Indeed, investing in growth stocks has clearly been the winning...
Published:
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
These four blue chip stocks with dependable, high-yield dividends should continue to deliver regardless of inflation.
Published:
These five blue chip dividend stocks would be ideal for investors who had to hold them forever, as they provide reliable streams of passive income.
Published:
The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we need it, to everyday pain remediation or allergy medications, big pharma...
Published:
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Published:
24/7 Insights The most shocking recall on this list is the 1982 Tylenol recall. Recalling the Galaxy Note 7 was a huge blow to Samsung’s brand. Shockingly, only two companies listed here went...
Published:
24/7 Insights With the S&P 500 up 15% year-to-date, a correction could be coming in the third quarter. Stocks that pay dividends will be in big demand when interest rates start to fall over the...
Published:
Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
Published: